Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Acute Pulmonary Embolism (YGGDRASIL)
NCT04283240Phase 1Completed
- Sponsor
- Aarhus University
- Start
- Mar 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sildenafil in pulmonary embolism (PE), sponsored by Aarhus University. Primary endpoint: Cardiac Index at 74 minutes. Started Mar 2015; status: completed.
02
Drugs
sildenafil
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT04283240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04283240.